TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis Susceptibility
TOLLIP 缺乏、免疫失调和结核病易感性
基本信息
- 批准号:10411553
- 负责人:
- 金额:$ 0.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAlveolusAnti-Inflammatory AgentsBCG VaccineBacille Calmette-Guerin vaccinationBiological Response ModifiersCD4 Positive T LymphocytesCause of DeathCell Differentiation processCell physiologyCessation of lifeChronicClinicalCollaborationsComplexCytokine ActivationDendritic CellsDendritic cell activationDiseaseEpigenetic ProcessEragrostisGenesGenetic PolymorphismGenetic TranscriptionGenetic VariationGenetic studyGoalsGrantGranulomaHost DefenseHumanImmuneImmune responseImmunityImmunologic FactorsImpairmentIndividualInfantInfectionInflammationInhalationInnate Immune ResponseIntegration Host FactorsInterferonsInterleukin-1Interleukin-10Interleukin-2Interleukin-6Knock-outKnockout MiceLeadLungMediatingMemoryModelingMolecularMusMycobacterium tuberculosisMyeloid CellsNuclearOutcomePathogenesisPathologyPersonsPhenotypePopulationPredispositionProductionPromoter RegionsProtein DeficiencyProteinsPublic HealthPulmonary PathologyRNAResearchRiskRoleSeveritiesSeverity of illnessSignal PathwaySouth AfricanStructure of parenchyma of lungT cell differentiationT cell responseT memory cellT-Cell ActivationT-LymphocyteTNF geneTOLLIP geneTestingTherapeuticTissuesTranscription InitiationTuberculosisTuberculosis VaccinesUntranslated RNAVaccine AdjuvantVaccine DesignVaccinesVariantWorkclinical phenotypecytokineexhaustexhaustionimmunological synapseimmunoregulationimprovedin vivoinnate immune pathwaysinnovationinsightmacrophagemonocytemouse modelmycobacterialnovelnovel vaccinespeptide deformylaseprogramsprospectiveprotein expressionprotein functionresponsetooltranscription factortuberculosis immunitytuberculosis treatmentvaccine developmentvaccine effectivenessvaccine formulationvaccine response
项目摘要
Project Summary/Abstract
Over one million people died from tuberculosis (TB) in 2016. Improved understanding of the host
factors that influence TB infection and TB disease severity is needed to improve TB treatments and vaccines.
Multiple lines of evidence show that excess inflammation worsens outcomes from M. tuberculosis (Mtb)
infection. After Mtb infection, macrophages and dendritic cells initiate the immune response, leading to
mycobacterial killing, granuloma formation, and T cell activation. The Toll-Interacting Protein (TOLLIP)
mediates the immune response to Mtb by dampening several innate immune pathways, including TLR and IL-1
signaling pathways. Our long-term goal is to determine the molecular and cellular mechanisms that influence
vaccine immunity and susceptibility to TB. Discovery of innate immune factors, including TOLLIP, that
influence vaccine development may influence vaccine design. The objective of this grant is to characterize the
role of TOLLIP in influencing T memory differentiation and persistence in the context of chronic TB or BCG
exposure. The central hypothesis is that TOLLIP deficiency – a phenotype we have discovered exists in
multiple population -- amplifies the innate immune response to Mtb in a deleterious fashion, weakening Mtb-
specific T cell responses and increasing TB susceptibility. The rationale is that identification of innate immune
factors that influence T cell immunity in a nuanced fashion provides a novel path toward rational vaccine
design. Our specific aims will test the following hypotheses: 1) TOLLIP deficiency in macrophages is caused by
alterations in the TOLLIP transcriptional complex and influences multiple signaling pathways within the
macrophage; 2) TOLLIP deficiency increases DC activation, which leads to increased T cell differentiation but
reduced vaccine effectiveness in humans, and 3) TOLLIP deficiency impairs lung-specific immunity,
particularly in the formation and persistence of resident memory T cells and exhausted T cells in knockout
mice. This contribution is significant because it will establish that TOLLIP regulates the innate immune
response and improves host defense against M. tuberculosis; this proposal may lead to improved vaccine
adjuvants and host-directed therapeutics to Mtb. The proposed work is innovative because we investigate the
mechanisms and effects of a functionally active variant of TOLLIP in humans and combine with a knockout
mouse model of infection, using novel tools to investigate an understudied, critical immune regulator. Insight
into immunoregulatory genes like TOLLIP is impactful because they may offer new targets for modifying the
immune response.
项目摘要/摘要
2016年有100多万人死于结核病。提高了对主机的了解
需要影响结核病感染和结核病严重程度的因素来改进结核病治疗和疫苗。
多条证据表明,过度炎症会恶化结核分枝杆菌(结核分枝杆菌)的预后。
感染。结核分枝杆菌感染后,巨噬细胞和树突状细胞启动免疫反应,导致
分枝杆菌杀灭、肉芽肿形成和T细胞激活。Toll相互作用蛋白(TOLLIP)
通过抑制包括TLR和IL-1在内的几种天然免疫途径来介导对结核分枝杆菌的免疫应答
信号通路。我们的长期目标是确定影响
疫苗免疫和对结核病的易感性。先天免疫因子的发现,包括TOLLIP,
影响疫苗开发可能会影响疫苗设计。这笔赠款的目的是为了描述
TOLLIP在影响慢性结核或卡介苗患者T记忆分化和持久性中的作用
曝光。中心假设是TOLLIP缺乏症--我们发现的一种表型存在于
多种群--以有害的方式放大对结核分枝杆菌的天然免疫反应,削弱结核分枝杆菌--
特异性T细胞反应和增加结核病易感性。其基本原理是识别先天免疫
以细微差别方式影响T细胞免疫的因素提供了一条通往合理疫苗的新途径
设计。我们的具体目标将检验以下假设:1)巨噬细胞中TOLLIP缺乏是由
TOLLIP转录复合体的改变并影响体内的多个信号通路
巨噬细胞;2)TOLLIP缺乏增加DC激活,从而导致T细胞分化增加,但
降低了疫苗对人类的效力,以及3)TOLLIP缺乏会损害肺部特异性免疫,
尤其是在基因敲除中驻留记忆T细胞和耗尽T细胞的形成和持续
老鼠。这一贡献意义重大,因为它将确立TOLLIP调节先天免疫
应答并提高宿主对结核分枝杆菌的抵抗力;这一建议可能导致改进疫苗
结核分枝杆菌的佐剂和宿主导向疗法。拟议的工作具有创新性,因为我们调查了
TOLLIP功能活性变异体与基因敲除联合作用的机制和作用
小鼠感染模型,使用新工具研究一种未被充分研究的关键免疫调节因子。洞察力
像TOLLIP这样的免疫调节基因是有影响的,因为它们可能为修改
免疫反应。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
BMI and Outcomes of SARS-CoV-2 Among US Veterans.
- DOI:10.1002/oby.23111
- 发表时间:2021-05
- 期刊:
- 影响因子:0
- 作者:Eastment MC;Berry K;Locke E;Green P;O'Hare A;Crothers K;Dominitz JA;Fan VS;Shah JA;Ioannou GN
- 通讯作者:Ioannou GN
Washington state satellite HIV clinic program: a model for delivering highly effective decentralized care in under-resourced communities.
- DOI:10.1080/09540121.2018.1481194
- 发表时间:2018-09
- 期刊:
- 影响因子:1.7
- 作者:Wood BR;Bell C;Carr J;Aleshire R;Behrens CB;Dunaway SB;Shah JA;Barnabas RV;Green ML;Ramers CB;Fina PL;Kim HN;Harrington RD
- 通讯作者:Harrington RD
Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2.
- DOI:10.1186/s12877-021-02340-5
- 发表时间:2021-07-06
- 期刊:
- 影响因子:4.1
- 作者:O'Hare AM;Berry K;Fan VS;Crothers K;Eastment MC;Dominitz JA;Shah JA;Green P;Locke E;Ioannou GN
- 通讯作者:Ioannou GN
Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture.
- DOI:10.7554/elife.84394
- 发表时间:2024-01-15
- 期刊:
- 影响因子:7.7
- 作者:Schurz H;Naranbhai V;Yates TA;Gilchrist JJ;Parks T;Dodd PJ;Möller M;Hoal EG;Morris AP;Hill AVS;International Tuberculosis Host Genetics Consortium
- 通讯作者:International Tuberculosis Host Genetics Consortium
Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
- DOI:10.1371/journal.pone.0203063
- 发表时间:2018
- 期刊:
- 影响因子:3.7
- 作者:Rahman SMM;Maliha UT;Ahmed S;Kabir S;Khatun R;Shah JA;Banu S
- 通讯作者:Banu S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Javeed Ali Shah其他文献
Javeed Ali Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Javeed Ali Shah', 18)}}的其他基金
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis
粘液纤毛清除对结核分枝杆菌发病机制的影响
- 批准号:
10666055 - 财政年份:2023
- 资助金额:
$ 0.76万 - 项目类别:
TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis Susceptibility
TOLLIP 缺乏、免疫失调和结核病易感性
- 批准号:
9493306 - 财政年份:2018
- 资助金额:
$ 0.76万 - 项目类别:
TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis Susceptibility
TOLLIP 缺乏、免疫失调和结核病易感性
- 批准号:
10121358 - 财政年份:2018
- 资助金额:
$ 0.76万 - 项目类别:
相似海外基金
Reverse Engineering the Alveolus: From cellular to microenvironment specification during development
对肺泡进行逆向工程:从开发过程中的细胞规范到微环境规范
- 批准号:
10534378 - 财政年份:2022
- 资助金额:
$ 0.76万 - 项目类别:
Alveolus as Incubator: Functional Genomic Dissection of the Host Response to SARS-CoV-2 Infection.
肺泡作为孵化器:宿主对 SARS-CoV-2 感染反应的功能基因组解剖。
- 批准号:
10245986 - 财政年份:2021
- 资助金额:
$ 0.76万 - 项目类别:
Reverse Engineering the Alveolus: From cellular to microenvironment specification during development
对肺泡进行逆向工程:从开发过程中的细胞规范到微环境规范
- 批准号:
10215602 - 财政年份:2019
- 资助金额:
$ 0.76万 - 项目类别:
The influence that the influence of the different exercise length, the neuromuscular electrical stimulation (NMES) in skeletal muscle, Vitamin C intake and exercise on alveolus and cytokine
不同运动时长、骨骼肌神经肌肉电刺激(NMES)、维生素C摄入和运动对肺泡和细胞因子的影响
- 批准号:
18K10751 - 财政年份:2018
- 资助金额:
$ 0.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Wnt-mediated epithelial-endothelial crosstalk in the generation and regeneration of the lung alveolus
Wnt介导的上皮-内皮串扰在肺泡生成和再生中的作用
- 批准号:
10326831 - 财政年份:2018
- 资助金额:
$ 0.76万 - 项目类别:
A bovine alveolus model to replace cattle in the study of host-pathogen interactions in bovine tuberculosis
牛肺泡模型替代牛用于牛结核病宿主与病原体相互作用的研究
- 批准号:
NC/M002047/1 - 财政年份:2016
- 资助金额:
$ 0.76万 - 项目类别:
Research Grant
Reverse Engineering the Alveolus: From cellular to microenvironment specification during development
对肺泡进行逆向工程:从开发过程中的细胞规范到微环境规范
- 批准号:
9223730 - 财政年份:2016
- 资助金额:
$ 0.76万 - 项目类别:
Bone augmentation of jaw and alveolus bone with coral block in preprosthetic surgery.
在假体前手术中用珊瑚块增强颌骨和牙槽骨。
- 批准号:
23592909 - 财政年份:2011
- 资助金额:
$ 0.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EXPRESSION AND FUNCTION OF CEACAM6 IN THE ALVEOLUS
CEACAM6 在肺泡中的表达和功能
- 批准号:
8054534 - 财政年份:2011
- 资助金额:
$ 0.76万 - 项目类别:
The novel therapeutic approach for emphysema by regeneration of microvessel and alveolus after intrapulmonary arterial administration of gelatin microspheres slowly releasing basic fibroblast growth factor(bFGF-GMS).
肺动脉内给予缓慢释放碱性成纤维细胞生长因子(bFGF-GMS)的明胶微球后,通过再生微血管和肺泡来治疗肺气肿的新方法。
- 批准号:
21390393 - 财政年份:2009
- 资助金额:
$ 0.76万 - 项目类别:
Grant-in-Aid for Scientific Research (B)